Today, the Dutch daily newspaper NRC Handelsblad published an extensive article about Kendrion and our role in the development of electric cars, especially in the sound systems that we produce.

Today we held a Capital Markets Day for analysts, investors, and shareholders community.

Kendrion today announced that it has entered into an agreement to sell its Automotive business in Europe and the United States to Solero Technologies LLC (“Solero Technologies”) and affiliates.

Kendrion is pleased to announce a long-term cooperation with Knorr-Bremse that will shape the future of its Sibiu Mobility electronics operations.

Kendrion as a pure-play industrial company: full focus on profitability

Medical technology: Automate processes safely with brakes from Kendrion Automating processes in medical technology requires maximum precision and safety. After all, life and limb are at stake here. In concrete terms, this means "zero tolerance" for the movements performed and "zero backlash" for the brake technology used. Our permanent and spring-applied brakes are ideally suited for sensitive applications in medical technology. We have consistently advanced our product portfolio in parallel with the rapid technological development in this field and today offers customized solutions that meet the high requirements across the board.

Kendrion reports strong first quarter with increased profitability

Kendrion posts stable performance of continuing operations

On track to achieve 2025 financial targets with a continued focus on organic growth

Kendrion reports solid first-half results in a challenging market